Skip to main content
OpenTrials
Completed

NCT Number: NCT04342676

Lymph Node Ratio and Kras Mutation in R Colon Cancer

clinical impact of LN ratio with Kras expression in colon cancer

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colon Cancer Stage III Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site

Age range

16 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Mansoura University Oncology Center

Al Mansurah, Dakahlia Governorate, 35516, Egypt

About this study

LNR and K ras were evaluated with correlated with different clinicopathological parameters of the patients, PFS and OS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stage III colon cancer

Exclusion criteria

  • Stage I, II, IV

Treatment and study plan

k ras

Device

K ras

Panitumumab

Drug

vectibex in stage iv

Other names: vectibex

Primary outcomes

  1. LNR and K ras were evaluated with correlated with different clinicopathological parameters (Gender, CEA, tumor size, tumor grade and response to treatment).

    Time frame: 2 years

    impact on response

Secondary outcomes

  1. LNR and K ras were evaluated and ASSOCIATION with PFS and OS.

    Time frame: 2 years

    impact on survival

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Lymph Node Ratio and Kras Mutation in Risk Stratification of Colon Cancer

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Apr 13, 2020
Registry last updated
Apr 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.